Soleno Therapeutics
About:
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Website: https://soleno.life/
Top Investors: Perceptive Advisors, Frazier Life Sciences, Woodline Partners, Abingworth, Commodore Capital
Description:
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Total Funding Amount:
$319M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Redwood City, California, United States
Founded Date:
1999-08-25
Contact Email:
info(AT)soleno.life
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-05-02
IPO Status:
Public
© 2025 bioDAO.ai